NEW YORK (GenomeWeb News) – Clinical Data’s PGxHealth division will provide testing services to PharmaCare Management Services, a large national pharmacy benefits manager, Clinical Data said last week.
 
Along with testing services, PGxHealth will help the PBM incorporate genetic testing into clinical programs used to select treatment options. Under the agreement, PGxHealth will initially offer clozapine and warfarin tests.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.